Concepedia

Richard L. Lalonde

RL

21

Publications

703

Citations

17

H-Index

1983

Active since

Affiliations

University of Tennessee Health Science Center(Current)

Pfizer (United States)

University of Memphis

University of Tennessee at Knoxville

International Life Sciences Institute India

Richard L. Lalonde is an author at University of Tennessee Health Science Center specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1983–2010

21

Publications

21

Acceleration of digoxin clearance by activated charcoal

Richard L. Lalonde, R. H. Deshpande, Philip P. Hamilton et al. · Clinical Pharmacology & Therapeutics · 1985 · 102 citations

A Single‐Blind, Crossover Comparison of the Pharmacokinetics and Cognitive Effects of a New Diazepam Rectal Gel with Intravenous Diazepam

James C. Cloyd, Richard L. Lalonde, Thomas E. Beniak et al. · Epilepsia · 1998 · 82 citations

Exposure‐Response Analysis in Patients With Schizophrenia to Assess the Effect of Asenapine on QTc Prolongation

Sunny Chapel, Matt Hutmacher, George M. Haig et al. · The Journal of Clinical Pharmacology · 2009 · 62 citations

, , +16

Performance Characteristics for Some Typical QT Study Designs Under the ICH E‐14 Guidance

Matthew M. Hutmacher, Sunny Chapel, Marilyn A. Agin et al. · The Journal of Clinical Pharmacology · 2008 · 44 citations

, , +11

Impact of Population Pharmacokinetic- Pharmacodynamic Analyses on the Drug Development Process

Stephen C. Olson, Howard N. Bockbrader, Rebecca A. Boyd et al. · Clinical Pharmacokinetics · 2000 · 38 citations

, , +7

Rows per page

1–5 of 21